Published in Nucleic Acids Res on August 25, 1989
Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet (1993) 2.46
Tetranucleotide repeat polymorphism in the LPL gene. Nucleic Acids Res (1990) 0.84
Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals. BMC Med Genet (2009) 0.80
Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum. Mediators Inflamm (2014) 0.77
Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis. Int J Environ Res Public Health (2017) 0.75
PCR assay for a polymorphic PvuII site in the LPL gene. Nucleic Acids Res (1990) 0.75
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1989) 0.75
Determination of nucleotide sequences in DNA. Science (1981) 6.02
Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res (1988) 1.99
Two polymorphisms in the human lipoprotein lipase (LPL) gene. Nucleic Acids Res (1987) 1.51
Nucleotide sequence of human cDNA coding for a lipoprotein lipase (LPL) cloned from placental cDNA library. Nucleic Acids Res (1989) 1.23
Detection of familial LPL deficiency by PvuII RFLP. Nucleic Acids Res (1989) 0.99
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia (1985) 3.65
Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax (2008) 3.30
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
A new apparatus for the accurate measurement of airway resistance in infancy. J Appl Physiol Respir Environ Exerc Physiol (1977) 3.09
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus. Lancet (1988) 2.92
DNA polymorphic haplotypes on the short arm of chromosome 11 and the inheritance of type I diabetes mellitus. J Med Genet (1986) 2.86
The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol (1971) 2.77
Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med (1998) 2.66
Caeruloplasmin: physiological and pathological perspectives. Crit Rev Clin Lab Sci (1981) 2.32
The need to change the method for defining mild airway obstruction. Eur Respir J (2011) 2.30
DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet (1983) 2.28
Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation (1982) 2.21
Regulation of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity in type II hyperlipoproteinaemia. Br Med J (1975) 2.15
Measurement of lung volumes by plethysmography. Eur Respir J (1997) 2.08
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun (1972) 2.06
A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol (1999) 2.04
Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res (1988) 1.99
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J (2010) 1.88
Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax (2004) 1.86
Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest (1985) 1.73
Airway function in infants newly diagnosed with cystic fibrosis. Lancet (2001) 1.72
A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation (1995) 1.66
Did Mendel falsify his data? QJM (2011) 1.64
A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet (1985) 1.64
The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol. Clin Sci Mol Med (1974) 1.61
The susceptibility to autoxidation of human red cell lipids in health and disease. Br J Haematol (1972) 1.60
Reference values for lung function: past, present and future. Eur Respir J (2010) 1.58
Specifications for equipment used for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J (2000) 1.57
Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med (1999) 1.55
Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Ophthalmol (1982) 1.52
Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem (2000) 1.52
Clinical application of regional lung function studies in infants and small children using 13N. Arch Dis Child (1975) 1.47
DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis (1989) 1.47
Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science (1983) 1.44
In vitro assessment of infant pulmonary function equipment. Pediatr Pulmonol (1995) 1.41
Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase. Proc Natl Acad Sci U S A (1987) 1.39
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest (1982) 1.39
Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39
Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology (1998) 1.36
Tidal forced expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J (2000) 1.33
Nasal resistance during infancy. Respir Physiol (1978) 1.30
Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood. Stat Med (2009) 1.30
Effect of nasogastric tubes on nasal resistance during infancy. Arch Dis Child (1980) 1.29
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Further separation of the apoproteins of the human plasma very low density lipoproteins. Biochim Biophys Acta (1970) 1.28
A new type of familial hypercholesterolaemia. Lancet (1975) 1.27
Compilation of reference values for lung function measurements in children. Eur Respir J Suppl (1989) 1.26
Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins. Am J Physiol (1980) 1.24
Tidal breath analysis for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J (2000) 1.24
Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age. Eur Respir J (2010) 1.24
Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin Sci Mol Med (1974) 1.23
The EPICure study: comparison of pediatric spirometry in community and laboratory settings. Pediatr Pulmonol (2008) 1.20
Lung development and early origins of childhood respiratory illness. Br Med Bull (1997) 1.20
Total respiratory compliance and functional residual capacity in young children. Pediatr Pulmonol (1987) 1.17
beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol (1983) 1.16
The influence of endotracheal tube leak on the assessment of respiratory function in ventilated children. Intensive Care Med (2001) 1.16
The functional growth and development of the lung during the first year of life. Early Hum Dev (1977) 1.16
Urinary copper excretion in rheumatoid arthritis. Ann Rheum Dis (1975) 1.15
Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion (1991) 1.15
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med (1985) 1.15
Glucose homeostasis in viral hepatitis. N Engl J Med (1970) 1.15
End products and fermentation balances for lactic streptococci grown aerobically on low concentrations of glucose. Appl Environ Microbiol (1977) 1.15
Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus. Science (1970) 1.14
Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care (1987) 1.14
Further characterization of apolipoproteins from the human plasma very low density lipoproteins. J Biol Chem (1970) 1.14
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest (1972) 1.13
Treatment of severe diabetic hypertriglyceridaemia by plasma exchange. Lancet (1978) 1.12
Further characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry (1970) 1.12
Specific airway conductance in relation to postconceptional age during infancy. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.11
Passive respiratory mechanics: the occlusion techniques. Eur Respir J (2001) 1.11
Improved esophageal balloon technique for use in infants. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.11
Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis. Thorax (2004) 1.10
High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J (1978) 1.09
Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest (1979) 1.08
The association between birthweight, sex, and airway function in infants of nonsmoking mothers. Am J Respir Crit Care Med (2001) 1.08
Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res (1983) 1.07
Association of prematurity, lung disease and body size with lung volume and ventilation inhomogeneity in unsedated neonates: a multicentre study. Thorax (2008) 1.07
Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins. J Lipid Res (1978) 1.07
Familial homozygous hypobetalipoproteinemia. Metabolism (1974) 1.07
The role of artificial ventilation, oxygen, and CPAP in the pathogenesis of lung damage in neonates: assessment by serial measurements of lung function. Pediatrics (1976) 1.06
Genetic studies of kanamycin resistance in Campylobacter jejuni. Antimicrob Agents Chemother (1986) 1.06
The numerical analysis of pressure-flow curves in infancy. Pediatr Pulmonol (1985) 1.06
Heart disease risk factors and hormone use in postmenopausal women. JAMA (1979) 1.06
Structure and polymorphic map of human lipoprotein lipase gene. Biochim Biophys Acta (1990) 1.06
Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia. Lancet (1969) 1.05
An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. J Clin Invest (1982) 1.04
Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man. Am J Physiol (1981) 1.04
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr (2000) 1.04
Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet (1985) 1.04
Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J (2001) 1.04
Bronchial hypersecretion in preterm neonates. Arch Dis Child (1982) 1.03